"Plaio Raises €4.3M for AI Pharma Solutions, Focuses on Platform Enhancements and Industry Partnerships"
Plaio Raises €4.3M in Funding
Plaio Secures €4.3M Funding for AI-Driven Pharma Solutions
Plaio (Linkedin), a pharmaceutical manufacturing company based in Iceland, recently raised €4.3M to enhance their AI Coplanner offering and expand partnerships in the pharmaceutical sector. With a growing client portfolio, Plaio is poised to revolutionize supply chain planning and drug development processes.
Funding Amount: €4.3 million
Industry: Pharmaceutical Manufacturing
Employee Count: 11-50
CEO: Johann Gudbjargarson (CEO Linkedin)
What Plaio needs to buy: Pharmaceutical companies, biopharmaceutical firms, and healthcare innovators are ideal partners for Plaio. They are seeking collaborations with AI technology firms, market research services, and sales and marketing expertise to enhance their platform capabilities, gain industry insights, and expand their market reach for customer acquisition.